These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17965046)

  • 1. Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.
    Lequerré T; Vittecoq O; Pouplin S; Klemmer N; Mejjad O; Daragon A; Prieur AM; Le Loët X
    Rheumatology (Oxford); 2007 Dec; 46(12):1860-2. PubMed ID: 17965046
    [No Abstract]   [Full Text] [Related]  

  • 2. On-demand anakinra treatment is effective in mevalonate kinase deficiency.
    Bodar EJ; Kuijk LM; Drenth JP; van der Meer JW; Simon A; Frenkel J
    Ann Rheum Dis; 2011 Dec; 70(12):2155-8. PubMed ID: 21859689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent arthritis as a unique manifestation of hyperimmunoglobulinaemia D.
    Martini G; Meneghesso D; Caroli F; Ceccherini I; Zulian F
    Rheumatology (Oxford); 2009 Feb; 48(2):199-201. PubMed ID: 19036780
    [No Abstract]   [Full Text] [Related]  

  • 4. Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra.
    Peciuliene S; Burnyte B; Gudaitiene R; Rusoniene S; Drazdiene N; Liubsys A; Utkus A
    Pediatr Rheumatol Online J; 2016 Mar; 14(1):19. PubMed ID: 27012807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe early-onset colitis revealing mevalonate kinase deficiency.
    Levy M; Arion A; Berrebi D; Cuisset L; Jeanne-Pasquier C; Bader-Meunier B; Jung C
    Pediatrics; 2013 Sep; 132(3):e779-83. PubMed ID: 23979089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, genetic, and therapeutic diversity in 2 patients with severe mevalonate kinase deficiency.
    Ruiz Gomez A; Couce ML; Garcia-Villoria J; Torres A; Baña Souto A; Yagüe J; Vilaseca MA; Ribes A; Aróstegui JI
    Pediatrics; 2012 Feb; 129(2):e535-9. PubMed ID: 22271696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency.
    Nevyjel M; Pontillo A; Calligaris L; Tommasini A; D'Osualdo A; Waterham HR; Granzotto M; Crovella S; Barbi E; Ventura A
    Pediatrics; 2007 Feb; 119(2):e523-7. PubMed ID: 17261617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature.
    Campanilho-Marques R; Brogan PA
    Clin Rheumatol; 2014 Nov; 33(11):1681-4. PubMed ID: 24531849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case of anakinra as a steroid-sparing agent for gout inflammation.
    Gratton SB; Scalapino KJ; Fye KH
    Arthritis Rheum; 2009 Sep; 61(9):1268-70. PubMed ID: 19714614
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent Fever, arthritis, lymphadenopathy, and hepatosplenomegaly.
    Megged O; Navon-Elkan P; Anikster Y; Kleid D
    Pediatr Infect Dis J; 2011 Feb; 30(2):182-5. PubMed ID: 21242751
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases.
    Botsios C; Sfriso P; Ostuni PA; Todesco S; Punzi L
    Rheumatology (Oxford); 2007 Jun; 46(6):1042-3. PubMed ID: 17449489
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency.
    Galeotti C; Meinzer U; Quartier P; Rossi-Semerano L; Bader-Meunier B; Pillet P; Koné-Paut I
    Rheumatology (Oxford); 2012 Oct; 51(10):1855-9. PubMed ID: 22740624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid A amyloidosis secondary to hyper IgD syndrome and response to IL-1 blockage therapy.
    Kallianidis AF; Ray A; Goudkade D; de Fijter JW
    Neth J Med; 2016 Jan; 74(1):43-6. PubMed ID: 26819362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease.
    Woo P
    Ann Rheum Dis; 2008 Mar; 67(3):281-2. PubMed ID: 18292104
    [No Abstract]   [Full Text] [Related]  

  • 16. Outburst of Macrophage Activation Syndrome in Mevalonate Kinase Deficiency: Comment on the Article by Schulert et al.
    Rigante D
    Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1615. PubMed ID: 25988345
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome.
    Delluc A; Limal N; Puéchal X; Francès C; Piette JC; Cacoub P
    Ann Rheum Dis; 2008 Feb; 67(2):278-9. PubMed ID: 18192308
    [No Abstract]   [Full Text] [Related]  

  • 18. Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA).
    Ohlsson V; Baildam E; Foster H; Jandial S; Pain C; Strike H; Ramanan AV
    Rheumatology (Oxford); 2008 Apr; 47(4):555-6. PubMed ID: 18321945
    [No Abstract]   [Full Text] [Related]  

  • 19. A case report of mevalonate kinase deficiency in a 14-month-old female with fevers and lower extremity weakness.
    Coppola T; Becken B; Van Mater H; McDonald MT; Panayotti GM
    BMC Pediatr; 2019 Jul; 19(1):245. PubMed ID: 31325964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When neonatal inflammation does not mean infection: an early-onset mevalonate kinase deficiency with interstitial lung disease.
    Pietrasanta C; Minoia F; Torreggiani S; Ronchi A; Gattorno M; Volpi S; Ceccherini I; Mosca F; Filocamo G; Pugni L
    Clin Immunol; 2019 Aug; 205():25-28. PubMed ID: 31096039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.